Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Mold inhalation causes innate immune activation, neural, cognitive and emotional dysfunction.
Journal: Brain, behavior, and immunity
Published: March 22, 2019
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 22, 2013
Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: December 11, 2012
A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
Journal: Transfusion
Published: November 21, 2012
Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia.
Journal: American journal of hematology
Published: October 11, 2012
Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials.
Journal: Anemia
Published: April 11, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026